# ZOSANO PHARMA CORP (ZSANXXXX)

> Institutional ownership reported to the SEC as of Q2 2022, from Form 13F filings. Source: https://holderbook.com/stocks/ZSANXXXX/

- Reporting holders: 1
- Reported value: $24.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Aisling Capital Management LP](https://holderbook.com/funds/1766721-aisling-capital-management-lp/) | $24.0K | 77,663 | 0.0% | 15 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2022 | 1 | $24.0K |
| Q1 2022 | 26 | $2.7M |
| Q4 2021 | 31 | $5.8M |
| Q3 2021 | 29 | $9.0M |
| Q2 2021 | 30 | $13.0M |
| Q1 2021 | 34 | $13.7M |
| Q4 2020 | 31 | $5.8M |
| Q3 2020 | 41 | $23.1M |
| Q2 2020 | 27 | $5.9M |
| Q1 2020 | 25 | $5.2M |
| Q4 2019 | 27 | $10.7M |
| Q3 2019 | 21 | $9.2M |